Cytokinetics, Inc. (CYTK)
60.77
+0.46
(+0.75%)
USD |
NASDAQ |
Dec 11, 16:00
60.75
-0.02
(-0.03%)
After-Hours: 20:00
Cytokinetics Cash from Investing (Quarterly): -70.98M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Jasper Therapeutics, Inc. | 0.00 |
| Lantheus Holdings, Inc. | -319.47M |
| Bristol Myers Squibb Co. | -1.702B |
| Pfizer Inc. | -2.43B |
| Regeneron Pharmaceuticals, Inc. | -402.90M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -107.50M |
| Cash from Financing (Quarterly) | 330.47M |
| Free Cash Flow | -453.38M |
| Free Cash Flow Per Share (Quarterly) | -0.974 |
| Free Cash Flow to Equity (Quarterly) | -455.65M |
| Free Cash Flow to Firm (Quarterly) | -90.54M |
| Free Cash Flow Yield | -6.27% |